Sandoz runs into legal dead end for biosimilar Etanercept (Enbrel)
The U.S. Supreme Court denied taking up Sandoz's petition for it to review earlier decisions that had favored Amgen in the long-running...
For more details contact us via
Phone, E-mail or Linkedin